← All trials
NCT04413344
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 5, 2020
- Primary completion
- Sep 30, 2021
- Completion date
- Sep 30, 2021
- First posted
- Jun 2, 2020
- Last posted
- Jun 2, 2020
- Enrollment
- 10
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Kyoto UniversityLead sponsor
- Mie UniversityStudy director
- Osaka UniversityCollaborator
- Kyoto UniversityOverall official - principal investigator
- Kyoto UniversityReponsible party - principal investigator
- Kyoto UniversityStudy director
- Asakayama HospitalCollaborator
- Asakayama General HospitalCollaborator
- Kawasaki Medical School HospitalCollaborator
- Mie UniversityCollaborator
- Time Therapeutics, Inc.Collaborator
- Tokushima UniversityCollaborator
- Tokyo Metropolitan Geriatric Medical CenterCollaborator
- Towa Pharmaceutical Co.,Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.